title: [Nephrotoxicity in the perinatal period. Evaluation of drug surveillance centers].
authors.forename: F
authors.initials: F
authors.lastname: Bavoux
authors.forename: C
authors.initials: C
authors.lastname: Bodiou
authors.forename: G
authors.initials: G
authors.lastname: Olive
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005333:Fetus / Q000187:drug effects*; D005602:France; D006801:Humans; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced / Q000453:epidemiology / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal
vernacular_title: Observations de néphrotoxicité en période périnatale. Bilan des Centres de Pharmacovigilance.